At a glance
ClinicalIndex Comparison RecordN/ACompleted· 252 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Retrospective Non-interventional Multicenter Patient Chart Data Study on Tofacitinib Realworld Experience in Ulcerative Colitis in Finland (FinTofUC)
In Brief
An observational study for Ulcerative Colitis. Completed, enrolled 252 participants across 1 site.
Detailed Summary
The aim of this study is to describe and evaluate clinical outcomes, treatment lines, and to identify the key characteristics of the patients treated with tofacitinib.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsUlcerative Colitis
CountriesFinland
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedOct 2021
Enrollment StartMay 2022
Primary CompletionNov 2022
TodayJul 2026
First PostedOct 19, 2021
Enrollment StartMay 30, 2022
Primary CompletionNov 1, 2022
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 4.7 years ago